Skip to main content
. Author manuscript; available in PMC: 2021 Jan 6.
Published in final edited form as: Leuk Res. 2018 Oct 9;74:89–96. doi: 10.1016/j.leukres.2018.10.002

Table 5.

Percentage change from baseline for peripheral blood samples taken on day 28 of cycle 1 and assessed for pSTAT3, using plasma inhibitory assay.

Patient ID Ruxolitinib Dose Cohort, mg K562 cells KU812 cells
pSTAT3 (Ser727), % change pSTAT5 (Tyr694), % change pSTAT3 (Tyr705), % change
7 10 +12 −55 −4
9 15 +12 −14 −4
10 15 +12 −62 −7
11 15 +12 −23 −12